Cubist Systematic Strategies, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 151 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$923,035
-36.3%
58,531
-21.4%
0.01%
-30.0%
Q2 2023$1,448,441
+34.1%
74,508
+95.7%
0.01%
+42.9%
Q1 2023$1,079,989
+497.2%
38,068
+515.3%
0.01%
+600.0%
Q4 2022$180,846
-57.8%
6,187
-35.9%
0.00%
-66.7%
Q2 2022$429,000
-31.6%
9,658
-23.8%
0.00%
-40.0%
Q1 2022$627,000
+47.9%
12,679
+52.3%
0.01%
+25.0%
Q4 2021$424,000
-40.0%
8,323
-34.4%
0.00%
-55.6%
Q3 2021$707,000
+98.0%
12,680
+52.1%
0.01%
+125.0%
Q2 2021$357,000
-46.6%
8,334
-47.9%
0.00%
-55.6%
Q1 2021$668,000
+66.6%
16,001
+86.1%
0.01%
+50.0%
Q4 2020$401,000
+61.0%
8,600
+46.6%
0.01%
+50.0%
Q3 2020$249,000
-0.8%
5,866
+7.4%
0.00%
-42.9%
Q1 2020$251,000
-24.4%
5,463
-6.8%
0.01%0.0%
Q3 2019$332,000
-31.3%
5,862
-32.4%
0.01%
-22.2%
Q2 2019$483,000
+13.1%
8,677
+2.5%
0.01%
-35.7%
Q1 2019$427,000
-54.9%
8,463
-64.0%
0.01%
-68.9%
Q4 2018$947,000
+142.2%
23,506
+258.7%
0.04%
+104.5%
Q3 2017$391,000
+33.9%
6,554
+77.0%
0.02%
+15.8%
Q2 2017$292,000
+421.4%
3,702
+168.7%
0.02%
+533.3%
Q1 2016$56,000
-80.9%
1,378
-65.2%
0.00%
-80.0%
Q3 2015$293,0000.0%3,962
+9.5%
0.02%
+7.1%
Q2 2015$293,000
-73.1%
3,618
-86.1%
0.01%
-73.6%
Q1 2015$1,088,00025,9720.05%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders